Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1981 1
1982 1
1983 1
1984 1
1986 1
1987 5
1988 1
1989 2
1990 5
1991 2
1992 5
1993 3
1994 4
1995 3
1996 5
1997 3
1998 4
1999 3
2000 3
2001 2
2002 2
2003 4
2004 6
2005 3
2006 7
2007 3
2008 8
2009 12
2010 10
2011 17
2012 20
2013 20
2014 23
2015 25
2016 18
2017 16
2018 66
2019 54
2020 66
2021 72
2022 74
2023 31
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23120995

558 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C. Fujita N, et al. Urol Oncol. 2020 Aug;38(8):684.e17-684.e24. doi: 10.1016/j.urolonc.2020.03.009. Epub 2020 Apr 9. Urol Oncol. 2020. PMID: 32278732
Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation.
Tanimoto R, Saika T, Ebara S, Kobayashi Y, Nasu R, Yamada D, Takamoto H, Miyaji Y, Nasu Y, Tsushima T, Kumon H. Tanimoto R, et al. World J Urol. 2018 Jun;36(6):889-895. doi: 10.1007/s00345-018-2196-8. Epub 2018 Jan 31. World J Urol. 2018. PMID: 29387931 Clinical Trial.
[Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
Ding XL, Yang DL, Yan RP, Li ZP, Ye CW, He J, Yu L, He SC, Li HD. Ding XL, et al. Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):308-312. doi: 10.3760/cma.j.issn.0253-3766.2018.04.014. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29730921 Chinese.
Randomized study of intravesical pirarubicin chemotherapy with low and intermediate-risk nonmuscle-invasive bladder cancer in Japan: Comparison of a single immediate postoperative intravesical instillation with short-term adjuvant intravesical instillations after transurethral resection.
Naya Y, Mikami K, Takaha N, Inoue Y, Fujihara A, Kanazawa M, Nakanishi H, Miyashita H, Ukimura O. Naya Y, et al. Medicine (Baltimore). 2018 Oct;97(42):e12740. doi: 10.1097/MD.0000000000012740. Medicine (Baltimore). 2018. PMID: 30334959 Free PMC article. Clinical Trial.
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
Di Stasi SM, Valenti M, Verri C, Liberati E, Giurioli A, Leprini G, Masedu F, Ricci AR, Micali F, Vespasiani G. Di Stasi SM, et al. Lancet Oncol. 2011 Sep;12(9):871-9. doi: 10.1016/S1470-2045(11)70190-5. Epub 2011 Aug 8. Lancet Oncol. 2011. PMID: 21831711 Clinical Trial.
558 results